On Aug. 29, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it would invest up to $18 million toward a new statewide initiative called the Collaborative Action Program for Liver Cancer (CAP). The CAP was formed to reverse the rising rates of liver cancer.

The targeted initiative builds upon more than $46 million in academic research and prevention grants addressing HCC that CPRIT has awarded since 2010. In addition to eight CPRIT grants providing HCC prevention services to rural and urban areas across the state, CPRIT funds research projects at Texas institutions exploring the causes and developing treatments for HCC.

These include a statewide multi-investigator research collaboration between all four Texas NCI-designated cancer centers (Baylor College of Medicine, The University of Texas MD Anderson Cancer Center, The University of Texas Southwestern Medical Center and The University of Texas Health Science Center at San Antonio).